PI Industries Ltd. Share Price

PI Industries shares plunge 22% after Q2 results

PI Industries shares have fallen 22% after weak Q2 results and slipped below Rs 1,700 on 9 November. Rs 1,500 support and Rs 2,000 resistance are key levels. PI Industries Limited [PIIND] shares have fallen approximately 22% since the Q2 results announced on 4 November 2026. On 9 November, the stock traded below Rs 1,700, its lowest level since July 2020. The selling pressure followed a sharp deterioration in consolidated Q2 numbers. Profit declined 70.1% to Rs 122.2 crore from Rs 409.3 crore year on year. Revenue fell 9.1% to Rs 1,701.8 crore from Rs 1,872.3 crore year on year. Profit contracted much faster than revenue, indicating significant pressure on earnings. The stock's fall below Rs 1,700 reflects continued weakness in price action. Rs 1,500 is the next stated support, while Rs 2,000 remains resistance. In my view, the combination of weak quarterly results and a steep price decline keeps the technical outlook under pressure. A move above Rs 2,000 would bring a stronger recovery into focus. A fall below Rs 1,500 would increase downside pressure and weaken the support case. Watch the price action around Rs 1,500 and any attempt to reclaim Rs 2,000. Stance: strongly bearish while below Rs 2,000, with Rs 1,500 as the key support. Disclaimer: I do not hold any position in this. This content is for informational purposes only and is not a recommendation to buy or sell. Investments in securities are subject to market risks. Please read all related documents carefully before investing.

PI Industries Q2 Profit Drops 70% Amid Cost Pressures

Imagine a company investing heavily in research, developing new products and expanding its business. But rising costs and pricing pressure begin to affect its profits. This is the situation faced by PI Industries (PIIND) in Q2 FY27. The company reported a 9% YoY decline in revenue to ₹17.02 billion. EBITDA dropped 57% to ₹2.33 billion, while its EBITDA margin contracted to 13.7%. The biggest concern was net profit, which fell 70% YoY to ₹1.22 billion. Higher input costs, energy expenses, pricing pressure, new product launch costs and continued investment in research and development affected the company's performance. However, the company operates across agricultural sciences, speciality chemicals and pharmaceutical services, with a presence in more than 40 countries. What Can We Learn? A company's revenue growth alone does not tell the complete story. Investors and learners should also understand EBITDA, profit margins, input costs and net profit before evaluating business performance. Quarterly results show how revenue, costs, margins and research investments together shape a company's profitability and future business performance over time. Tags: #PIIndustries #Q2FY27Results #StockMarketLearning #IndianStockMarket #Nifty500 #QuarterlyResults #FinancialEducation Disclaimer: This post is strictly for educational purposes. It is not a stock recommendation, investment advice or a buy/sell signal.

Nifty midcap, Nifty JR analysis for 6/11/2026

1. Nifty MidSelect (Current: 13,968) Current Market Position: Trading at 13,968, comfortably above the key inflection threshold. Long Bias / Bullish Condition: Maintain long positions as long as the index sustains above 13,600. This acts as immediate short-term support and acts as a trailing risk-management line. Conditional Short Trigger: A shift in bias to short setups is strictly conditional on breaking and sustaining below 13,600. Below this pivot, downside momentum is expected to accelerate toward deeper support zones. 2. Nifty JR / Nifty Next 50 (Current: 71,768) Current Market Position: Trading at 71,768, reflecting underlying strength. Long Bias / Bullish Condition: Hold existing long positions or look for continuation setups while the index trades above 70,100. Conditional Short Trigger: Short positions should only be considered if the index breaches and sustains below 70,100, invalidating the immediate bullish structure. F&O top looser was : PIIND

PI Industries: 19% Fall Puts Earnings Recovery in Focus

PIIND Q2 results show a sharp fall in profitability, led by weakness in export-led agrochemicals. Revenue fell 9%, EBITDA 57% & PAT 70% Why the decline? Agrochemical exports fell 18% amid weak global demand, competition from generic products & pricing pressure. Domestic revenue grew 19%, but couldn't offset export weakness. Gross margin fell from 57% to 49%. Input costs rose 5%, with the company not actively passing on cost increases. Higher R&D, energy & new-business expenses added pressure, pulling EBITDA margin down to 13.9% from 28.9% Management outlook: Near-term margins remain under pressure. The earnings-call indicates gross margins could stay around 48-49% over the next 2-3 quarters. Management also expects FY27 revenue to remain broadly flattish. Growth priorities: • Commercialisation of 5+ new products in FY27, with a pipeline of 20+ • Biologicals growth: 250%+ globally & 45%+ domestically • Scaling Health Sciences & Pharma CRDMO, including commercial GMP manufacturing of Galidesivir API • Unveiling of Pioxazon, PI's indigenous insecticide powered by Pioxaniliprole, on 31 October 2026 Investment Outlook PI's diversification is progressing, backed by net cash of ₹3,573 crore. Trade working capital reduced by 18 days in H1 FY27, releasing cash & supporting financial flexibility. However, newer businesses are not yet large enough to offset weakness in core agrochemical exports. The market reaction reflects concerns over the pace of earnings recovery Investor takeaway: This is an earnings reset, not just a price correction. The long-term opportunity remains, but near-term visibility has weakened. Fresh investors should wait for export recovery, margin stabilisation & EBITDA improvement before considering an entry. Existing investors should reassess the original investment thesis rather than average down solely because the stock has fallen Sustainable recovery depends on a revival in core agrochemical profitability, supported by growth in newer businesses

PI Industries crashes 20% to six-year low, support at 1,500

PI Industries fell as much as 20% after Q2 profit dropped 70.1% to Rs 122.2 crore, with support at Rs 1,500 and resistance at Rs 2,250. PI Industries Limited [ PIIND ] fell as much as 20% to Rs 1,749.50 on 5 November, its lowest level since September 2020, after weak Q2 FY27 results. The stock traded near Rs 1,769, about 63.6% below its September 2024 high. Consolidated profit fell 70.1% to Rs 122.2 crore from Rs 409.3 crore. Revenue fell 9.1% to Rs 1,701.8 crore from Rs 1,872.3 crore. EBITDA margin dropped to 13.7% from 28.9%, as agrochemical exports fell about 18%, input costs rose and pricing pressure grew. The weekly chart shows a persistent downtrend of lower highs and lower lows since the September 2024 peak, now accelerating. A bounce needs to reclaim Rs 2,250, the earlier breakdown zone, to matter. Support is Rs 1,500. Resistance is Rs 2,250. A weekly close below Rs 1,500 would extend the fall. A weekly close above Rs 2,250 would signal a trend change. Margin recovery is now the main factor. The next results need to show whether the pressure from input costs and pricing is easing. Volume at the Rs 1,749.50 low is the key signal today. Disclosure: I do not hold any position in this stock. This is not a recommendation to buy or sell. Investments in securities markets are subject to market risks. Read all related documents carefully before investing.

PI Industries shares dropped nearly 10% today

PIIND PI Industries shares dropped nearly 10% today after reporting weak Q2 FY27 results, with net profit plunging over 70% year-on-year due to margin contraction and declining agrochemical exports. Domestic revenue grew, but global demand weakness and rising input costs weighed heavily on performance. 📉 Key Financial Highlights (Q2 FY27) Revenue: ₹1,702 crore, down 9% YoY (vs ₹1,872 crore last year). EBITDA: ₹232 crore, down 57% YoY; margin contracted to 13.7% (vs 28.9%). Net Profit: ₹118 crore, down 71% YoY (vs ₹407 crore last year). Consolidated Net Profit: ₹1,222 million, missing estimates of ₹2,720 million. Agrochemical Exports: Fell 18% YoY due to subdued global demand. Domestic Revenue: Grew 19% YoY, showing resilience in India. Pharma Segment: Revenue up 19.7% YoY and 40% sequentially. 📊 Stock Market Reaction Share Price: Trading at ₹1,978, down 9.55% today. 52-Week Range: ₹2,006 – ₹3,829. Year-to-Date Performance: Down 32.46%. Volatility: Beta at 1.44, indicating higher-than-market volatility.